# gmpbridge.com ## Posts - [Annex 1 Contamination Control Strategy: Why Gaps Stay Open](https://gmpbridge.com/annex-1-gaps/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [FDA CMC Flexibilities for Cell and Gene Therapy](https://gmpbridge.com/fda-cmc-flexibilities-cell-gene-therapy/): FDA gives CGT sponsors more room to tailor CMC development. The opportunity is real, but only when flexibility is supported by science, lifecycle planning and sponsor ownership. - [Implementierung einer Contamination Control Strategy (CCS) in der aseptischen Biologika-Herstellung](https://gmpbridge.com/contamination-control-strategy-annex1-case-study/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Contamination Control Strategy (CCS) Implementation in Aseptic Biologics Manufacturing](https://gmpbridge.com/contamination-control-strategy-annex1-case-study/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Verkürzung der Chargenfreigabezeit um 40 % in der Herstellung steriler Injektionspräparate](https://gmpbridge.com/batch-release-time-reduction-sterile-injectables/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Reducing Batch Release Time by 40% in Sterile Injectables Manufacturing](https://gmpbridge.com/batch-release-time-reduction-sterile-injectables/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [QMS-Implementierung für klinische Biotechnologie auf dem Weg zur kommerziellen Fertigung](https://gmpbridge.com/qms-implementation-clinical-stage-biotech/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [QMS Implementation for Clinical Biotech Scaling Towards Commercial Manufacturing](https://gmpbridge.com/qms-implementation-clinical-stage-biotech/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Globales Qualitätsharmonisierungsprogramm an Biologika-Standorten](https://gmpbridge.com/quality-management-system-harmonization/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Global Quality Harmonization Program Across Biologics Sites](https://gmpbridge.com/quality-management-system-harmonization/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Lieferantenqualifizierungs- und Auditprogramm für einen Fill-&-Finish-Hersteller](https://gmpbridge.com/supplier-qualification-audit-program-sterile-manufacturing/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Supplier Qualification and Audit Program for a Fill & Finish Manufacturer](https://gmpbridge.com/supplier-qualification-audit-program-sterile-manufacturing/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Due-Diligence-Audit für einen US-Biotech-Investor zur Bewertung einer europäischen Akquisition](https://gmpbridge.com/due-diligence-audit-biotech-acquisition/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Due Diligence Audit for a US Biotech Investor Evaluating a European Acquisition](https://gmpbridge.com/due-diligence-audit-biotech-acquisition/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Herstellungsstrategie & Qualitätsüberwachungsprogramm für ein Biotech-Unternehmen in der klinischen Phase unter Einsatz von CDMOs](https://gmpbridge.com/biotech-cdmo-quality-oversight/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Manufacturing Strategy & Quality Oversight Program for a Clinical-Stage Biotech Using CDMOs](https://gmpbridge.com/biotech-cdmo-quality-oversight/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Pre-Approval (PAI) FDA-Scheinaudits in CAR-T- und viralen Vektor-Produktionsstätten](https://gmpbridge.com/fda-inspection-readiness-mock-audit-cgt-case-study/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Pre-Approval (PAI) FDA Mock Audits in CAR-T and Viral Vector Manufacturing Sites](https://gmpbridge.com/fda-inspection-readiness-mock-audit-cgt-case-study/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Sanierung aseptischer Abläufe: Aufsicht, EM und Neugestaltung der Sterilitätssicherung](https://gmpbridge.com/sterility-assurance-remediation-sterile-biologics/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Remediation of Aseptic Operations: Oversight, EM, and Sterility Assurance Redesign](https://gmpbridge.com/sterility-assurance-remediation-sterile-biologics/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Reduzierung der Chargenfreigabezeit in der Biopharmaindustrie](https://gmpbridge.com/batch-release-time-reduction-in-biopharma/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Batch Release Time Reduction in Biopharma](https://gmpbridge.com/batch-release-time-reduction-in-biopharma/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Die KI-Chance im Bereich Biopharma-Qualität](https://gmpbridge.com/ai-in-biopharma-quality/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [The AI Opportunity in Bipharma Quality](https://gmpbridge.com/ai-in-biopharma-quality/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Einblicke in die Biopharma M&A Due Diligence](https://gmpbridge.com/biopharma-due-diligence-audit/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Inside Biopharma M&A Due Diligence](https://gmpbridge.com/biopharma-due-diligence-audit/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [FDA-Bereitschaft in Europa](https://gmpbridge.com/fda-readiness-european-biopharma/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [FDA Readiness in Europe](https://gmpbridge.com/fda-readiness-european-biopharma/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Erste FDA PAI PLI für EU-Zell- und Gentherapiestandorte](https://gmpbridge.com/first-fda-pai-pli-for-eu-cell-and-gene-therapy-sites-how-to-prepare/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [First FDA PAI PLI for EU Cell and Gene Therapy Sites](https://gmpbridge.com/first-fda-pai-pli-for-eu-cell-and-gene-therapy-sites-how-to-prepare/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Leiter der Qualitätssicherung im Bereich Biopharma](https://gmpbridge.com/quality-leader-in-biopharma-first-100-days/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [QA leader in biopharma](https://gmpbridge.com/quality-leader-in-biopharma-first-100-days/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Vereinfachung des Qualitätsmanagementsystems](https://gmpbridge.com/qms-simplification-biologics-atmp/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [QMS Simplification](https://gmpbridge.com/qms-simplification-biologics-atmp/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Warum die Qualitätssicherung mitreden muss](https://gmpbridge.com/qa-leadership-in-biopharma-why-qa-needs-a-seat-at-the-table/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Why QA Needs a Seat at the Table](https://gmpbridge.com/qa-leadership-in-biopharma-why-qa-needs-a-seat-at-the-table/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] ## Pages - [Kontakt](https://gmpbridge.com/contact/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Contact](https://gmpbridge.com/contact/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Datenschutzerklärung](https://gmpbridge.com/privacy-policy/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Privacy Policy](https://gmpbridge.com/privacy-policy/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Impressum](https://gmpbridge.com/legal-notice/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Legal Notice](https://gmpbridge.com/legal-notice/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [GMP-Bereitschaft für den Übergang von der klinischen in die kommerzielle Phase](https://gmpbridge.com/biotech-gmp-consulting/clinical-to-commercial-gmp-readiness/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Clinical-to-Commercial GMP Readiness](https://gmpbridge.com/biotech-gmp-consulting/clinical-to-commercial-gmp-readiness/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Due-Diligence-Prüfungen für Investoren und Käufer](https://gmpbridge.com/biotech-gmp-consulting/biotech-due-diligence-audits/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Due Diligence Audits for Investors and Buyers](https://gmpbridge.com/biotech-gmp-consulting/biotech-due-diligence-audits/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Konzeption und Realisierung von Qualitätsmanagementsystemen](https://gmpbridge.com/biotech-gmp-consulting/biotech-qms-design-implementation/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [QMS Design and Implementation](https://gmpbridge.com/biotech-gmp-consulting/biotech-qms-design-implementation/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Bewertung, Qualifizierung und Überwachung von CDMO-Anbietern](https://gmpbridge.com/biotech-gmp-consulting/biotech-cdmo-oversight-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [CDMO Evaluation, Qualification and Oversight](https://gmpbridge.com/biotech-gmp-consulting/biotech-cdmo-oversight-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Beratung zu Zulassungsfragen und CMC](https://gmpbridge.com/biotech-gmp-consulting/biotech-cmc-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Regulatory & CMC Consulting](https://gmpbridge.com/biotech-gmp-consulting/biotech-cmc-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Beratung zu Sterilitätssicherung und Umsetzung von Annex 1](https://gmpbridge.com/biopharma-consulting-services/sterility-assurance-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Sterility Assurance and Annex 1 Compliance Consulting](https://gmpbridge.com/biopharma-consulting-services/sterility-assurance-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Vereinfachung und Harmonisierung von Qualitätssystemen](https://gmpbridge.com/biopharma-consulting-services/qms-simplification-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Quality System Simplification and Harmonization](https://gmpbridge.com/biopharma-consulting-services/qms-simplification-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Operative Exzellenz in der aseptischen Fertigung](https://gmpbridge.com/biopharma-consulting-services/operational-aseptic-manufacturing-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Operational Excellence in Aseptic Manufacturing](https://gmpbridge.com/biopharma-consulting-services/operational-aseptic-manufacturing-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Inspektionsbereitschaft und Regulatorische Sanierung](https://gmpbridge.com/biopharma-consulting-services/gmp-inspection-readiness-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Inspection Readiness and Regulatory Remediation](https://gmpbridge.com/biopharma-consulting-services/gmp-inspection-readiness-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [FDA-Inspektionsbereitschaft und Mock Audits](https://gmpbridge.com/biopharma-consulting-services/fda-inspection-readiness-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [FDA Inspection Readiness and Mock Audits](https://gmpbridge.com/biopharma-consulting-services/fda-inspection-readiness-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [CDMO-Qualitätsüberwachung und Lieferantenkontrolle für Biopharma](https://gmpbridge.com/biopharma-consulting-services/cdmo-oversight-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [CDMO Quality Oversight and Supplier Control for Biopharma](https://gmpbridge.com/biopharma-consulting-services/cdmo-oversight-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Biotech-CGT-Lösungen](https://gmpbridge.com/biotech-gmp-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Biotech CGT Solutions](https://gmpbridge.com/biotech-gmp-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Biopharma-GMP-Consulting](https://gmpbridge.com/biopharma-consulting-services/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Biopharma GMP Consulting](https://gmpbridge.com/biopharma-consulting-services/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [KI in der GxP-Beratung](https://gmpbridge.com/ai-in-gxp-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [AI in GxP Consulting](https://gmpbridge.com/ai-in-gxp-consulting/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Erfolgsgeschichten](https://gmpbridge.com/success-stories/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Success Stories](https://gmpbridge.com/success-stories/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Über uns](https://gmpbridge.com/biopharma-gmp-consulting-about/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [About Us](https://gmpbridge.com/biopharma-gmp-consulting-about/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Blog](https://gmpbridge.com/insights/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Blog](https://gmpbridge.com/insights/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Startseite](https://gmpbridge.com/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] - [Home](https://gmpbridge.com/): Annex 1 Is No Longer New. Why Are So Many Contamination Control Gaps Still Open? GMP Bridge Content Team 28.09.2026 Biopharma The revised EU GMP Annex 1 came into operation in August 2023. Its final deferred requirement, point 8.123, followed in August 2024.This is no longer a new regulation. The implementation deadline is not approaching. It passed.By now, many sterile manufacturers have completed at least one Annex 1 gap assessment. They have issued or revised their Contamination Control Strategy, created remediation trackers, launched workstreams and marked hundreds of actions complete.And yet, in our current work across sterile manufacturing and advanced-therapy environments, […] ## Optional - [Agent (MCP protocol)](websites-agents.hostinger.com/gmpbridge.com/mcp) [comment]: # (Generated by Hostinger Tools Plugin)